Important and exciting update for patients with AMN:
Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study
Ver el artículo en el link:
Link to "Facebook/ STOP ALD FOUNDATION"
View My Stats